JP2009528991A5 - - Google Patents

Download PDF

Info

Publication number
JP2009528991A5
JP2009528991A5 JP2008555308A JP2008555308A JP2009528991A5 JP 2009528991 A5 JP2009528991 A5 JP 2009528991A5 JP 2008555308 A JP2008555308 A JP 2008555308A JP 2008555308 A JP2008555308 A JP 2008555308A JP 2009528991 A5 JP2009528991 A5 JP 2009528991A5
Authority
JP
Japan
Prior art keywords
aliphatic
disease
compound according
halo
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555308A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009528991A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/003767 external-priority patent/WO2007095223A2/en
Publication of JP2009528991A publication Critical patent/JP2009528991A/ja
Publication of JP2009528991A5 publication Critical patent/JP2009528991A5/ja
Pending legal-status Critical Current

Links

JP2008555308A 2006-02-14 2007-02-12 プロテインキナーゼの阻害剤として有用なピロロ(3,2−c)ピリジン Pending JP2009528991A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77314306P 2006-02-14 2006-02-14
PCT/US2007/003767 WO2007095223A2 (en) 2006-02-14 2007-02-12 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases

Publications (2)

Publication Number Publication Date
JP2009528991A JP2009528991A (ja) 2009-08-13
JP2009528991A5 true JP2009528991A5 (cg-RX-API-DMAC7.html) 2010-03-11

Family

ID=38180574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555308A Pending JP2009528991A (ja) 2006-02-14 2007-02-12 プロテインキナーゼの阻害剤として有用なピロロ(3,2−c)ピリジン

Country Status (7)

Country Link
US (1) US7659283B2 (cg-RX-API-DMAC7.html)
EP (1) EP2004645A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009528991A (cg-RX-API-DMAC7.html)
CN (1) CN101848909A (cg-RX-API-DMAC7.html)
AU (1) AU2007215161A1 (cg-RX-API-DMAC7.html)
CA (1) CA2641254A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007095223A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9512125B2 (en) 2004-11-19 2016-12-06 The Regents Of The University Of California Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
NZ592968A (en) 2006-01-17 2012-08-31 Vertex Pharma Azaindoles substituted with either triazine or pyrimidine useful as inhibitors of janus kinases consisting of JAK1, JAK2, JAK3, and TYK2
KR20150038395A (ko) 2006-04-04 2015-04-08 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 키나제 길항물질
WO2008079346A1 (en) 2006-12-21 2008-07-03 Vertex Pharmaceuticals Incorporated 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
US20110160232A1 (en) 2007-10-04 2011-06-30 Pingda Ren Certain chemical entities and therapeutic uses thereof
EP2262498A2 (en) * 2008-03-10 2010-12-22 Vertex Pharmceuticals Incorporated Pyrimidines and pyridines useful as inhibitors of protein kinases
WO2009114870A2 (en) 2008-03-14 2009-09-17 Intellikine, Inc. Kinase inhibitors and methods of use
US8993580B2 (en) 2008-03-14 2015-03-31 Intellikine Llc Benzothiazole kinase inhibitors and methods of use
MX2011000216A (es) 2008-07-08 2011-03-29 Intellikine Inc Inhibidores de cinasa y metodos para su uso.
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
US8980899B2 (en) 2009-10-16 2015-03-17 The Regents Of The University Of California Methods of inhibiting Ire1
KR101173678B1 (ko) 2010-10-20 2012-08-13 한국과학기술연구원 피롤로[3,2-c]피리딘 유도체 및 그의 제조 방법
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
WO2013077921A2 (en) 2011-09-02 2013-05-30 The Regents Of The University Of California Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
CA2886240A1 (en) 2012-09-26 2014-04-03 The Regents Of The University Of California Modulation of ire1
DK3023100T3 (da) 2013-07-18 2019-05-27 Taiho Pharmaceutical Co Ltd Antitumorlægemiddel til intermitterende administration af fgfr-hæmmer
JP6084292B2 (ja) 2013-07-18 2017-02-22 大鵬薬品工業株式会社 Fgfr阻害剤耐性癌の治療薬
PT3068776T (pt) 2013-11-13 2019-08-26 Vertex Pharma Inibidores da replicação de vírus da gripe
HUE038820T2 (hu) 2013-11-13 2018-11-28 Vertex Pharma Eljárás influenzavírusok replikációjának inhibitorai elõállítására
US9546166B2 (en) 2014-07-31 2017-01-17 Merck Patent Gmbh Indolizine derivatives and their use in neurodegenerative diseases
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3426637B1 (en) * 2016-03-11 2022-02-09 Angel Pharmaceutical Co., Ltd. Compounds and methods for modulating bruton's tyrosine kinase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59710417D1 (de) * 1996-03-15 2003-08-14 Novartis Ag N-7 HETEROCYCLYL-PYRROLO[ 2,3-d]PYRIMIDINE UND IHRE VERWENDUNG
HRP20000209A2 (en) * 1997-10-20 2001-04-30 Hoffmann La Roche Bicyclic kinase inhibitors
CZ2001959A3 (cs) * 1998-09-18 2001-12-12 Basf Aktiengesellschaft 4-Aminopyrrolopyrimidiny jako inhibitory kinasy
NZ510588A (en) * 1998-09-18 2003-08-29 Abbott Gmbh & Co Pyrrolopyrimidines as protein kinase inhibitors
WO2000038683A1 (en) * 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company THROMBIN OR FACTOR Xa INHIBITORS
US20040235867A1 (en) * 2001-07-24 2004-11-25 Bilodeau Mark T. Tyrosine kinase inhibitors
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
TW200538453A (en) * 2004-04-26 2005-12-01 Bristol Myers Squibb Co Bicyclic heterocycles as kinase inhibitors
EP2325184A1 (en) * 2004-06-30 2011-05-25 Vertex Pharmceuticals Incorporated Azaindoles useful as inhibitors of protein kinases
EP1874769B1 (de) 2005-04-25 2011-09-14 Merck Patent GmbH Neuartige aza-heterozyklen als kinase-inhibitoren

Similar Documents

Publication Publication Date Title
JP2009506123A5 (cg-RX-API-DMAC7.html)
JP2009526849A5 (cg-RX-API-DMAC7.html)
JP2015528447A5 (cg-RX-API-DMAC7.html)
JP2021176902A (ja) ピロロ[1,2−b]ピリダジン誘導体
JP2021504443A (ja) スルホンピリジンアルキルアミド置換ヘテロアリール化合物
JP2007519742A5 (cg-RX-API-DMAC7.html)
JP2020537657A5 (cg-RX-API-DMAC7.html)
JP2009532475A5 (cg-RX-API-DMAC7.html)
JP2020505395A5 (cg-RX-API-DMAC7.html)
RU2012142550A (ru) Производные пирролопиразина и их применение в качестве ингибиторов jak и syk
JP2017531002A5 (cg-RX-API-DMAC7.html)
JP2020503010A5 (cg-RX-API-DMAC7.html)
RU2014110623A (ru) Пирролопиразиновые ингибиторы киназы
EP3269711B1 (en) Stable apremilast crystal form ii free of solvates, and preparation method therefor
HRP20161010T1 (hr) C5ar antagonisti
JP2018536705A5 (cg-RX-API-DMAC7.html)
RU2006109108A (ru) Соединения, обладающие активностью антагонистов crth2 рецепторов
CA2936551A1 (en) Substituted pyrrolopyridines and pyrrolopyrazines for treating cancer or inflammatory diseases
KR20160117614A (ko) Btk 억제제의 염 및 고체 형태
JP2011520896A5 (cg-RX-API-DMAC7.html)
JP2007513072A5 (cg-RX-API-DMAC7.html)
CA2491895A1 (en) Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
JP2012041365A5 (cg-RX-API-DMAC7.html)
JP2010509342A5 (cg-RX-API-DMAC7.html)
RU2007120518A (ru) ПИРАЗОЛО [1,5,-a] ПИРИМИДИНЫ, ПРИМЕНЯЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ПРОИЕИНКИНАЗ